TICKERNOMICS Sign up
Last Update: 2023-10-04 11:36:09
IsoPlexis Corp ( ISO ) https://isoplexis.com
0.76USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
14.73%
-58.15%
ISO
SPY
36.71%
ISO
0.00%
SPY
70.96%
ISO
0.00%
SPY
262.36%
ISO
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
29.94
45.75
0.11
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.27
1.79
0.73
-171.40
0.00
-0.38
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-943.32
-232.49
-906.69
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.69
-281.09
-277.11
0.00
Other Earnings and Cash Flow Stats:
IsoPlexis Corp ( ISO ) Net Income TTM ($MM) is -156.98
IsoPlexis Corp ( ISO ) Operating Income TTM ($MM) is -151.67
IsoPlexis Corp ( ISO ) Owners' Earnings Annual ($MM) is 0.00
IsoPlexis Corp ( ISO ) Current Price to Owners' Earnings ratio is 0.00
IsoPlexis Corp ( ISO ) EBITDA TTM ($MM) is -146.83
IsoPlexis Corp ( ISO ) EBITDA Margin is -906.69%
Capital Allocation:
IsoPlexis Corp ( ISO ) has paid 0.00 dividends per share and bought back 0.146535 million shares in the past 12 months
IsoPlexis Corp ( ISO ) has increased its debt by 0.012999999999998 million USD in the last 12 months
Capital Structure:
IsoPlexis Corp ( ISO ) Interest-bearing Debt ($MM) as of last quarter is 53
IsoPlexis Corp ( ISO ) Annual Working Capital Investments ($MM) are -25
IsoPlexis Corp ( ISO ) Book Value ($MM) as of last quarter is 41
IsoPlexis Corp ( ISO ) Debt/Capital as of last quarter is 129%
Other Balance Sheet Stats:
IsoPlexis Corp ( ISO ) has 37 million in cash on hand as of last quarter
IsoPlexis Corp ( ISO ) has 17 million of liabilities due within 12 months, and long term debt 46 as of last quarter
IsoPlexis Corp ( ISO ) has 39 common shares outstanding as of last quarter
IsoPlexis Corp ( ISO ) has 0 million USD of preferred stock value
Academic Scores:
IsoPlexis Corp ( ISO ) Altman Z-Score is -5.93 as of last quarter
IsoPlexis Corp ( ISO ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
IsoPlexis Corp ( ISO ) largest shareholder is Glenview Capital Management LLC owning 1970000 shares at 1.50 ($MM) value
Nachum Shamir(an insider) Bought 10253 shares of IsoPlexis Corp ( ISO ) for the amount of $19378.17 on 2022-08-30
15.52% of IsoPlexis Corp ( ISO ) is held by insiders, and 76.92% is held by institutions
IsoPlexis Corp ( ISO ) went public on 2021-10-08
Other IsoPlexis Corp ( ISO ) financial metrics:
FCF:-145.40
Unlevered Free Cash Flow:-81.58
EPS:-3.52
Operating Margin:-943.32
Gross Profit Margin:-232.49
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-336.53
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About IsoPlexis Corp ( ISO ) :
IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut. As of March 21, 2023, IsoPlexis Corporation operates as a subsidiary of Berkeley Lights, Inc.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.